Pharma and Biotech Daily: Sanofi's Success, CRISPR

Pharma and Biotech Daily: Sanofi's Success, CRISPR Breakthroughs, and Industry Updates

Listen now

Description

Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world.Sanofi beat third-quarter forecasts with a 381% growth in sales of its newly launched respiratory syncytial virus antibody, Beyfortus, bringing in almost $700 million. Analysts expect similar sales in the fourth quarter. Meanwhile, Pfizer CEO Albert Bourla is facing pressure from activist investor Starboard Value, but analysts are supporting him. In other news, Inte...

More Episodes

See all »

Pharma and Biotech Daily: Merck's $3 Billion Commitment and Industry Updates

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Merck has committed up to $3 billion in a deal with Lanova Medicines focused on PD-1/VEGF. The deal comes as Merck faces competition from Bristol Myers Squibb in...

Published 11/15/24

Pharma and BioTech Daily

Published 11/15/24

Pharma and Biotech Daily: Navigating Challenges and Opportunities in the Industry

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Amgen's obesity candidate, maritide, faced new safety concerns related to bone density, causing a drop in the company's stock. Biogen's shares have also plummeted due to...

Published 11/14/24